ARDELYX, INC. Property, Plant and Equipment, Gross
ARDELYX, INC. (ARDX) had Property, Plant and Equipment, Gross of $4.83 million as of 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-02-19
- 2025-12-31: Property, Plant and Equipment, Gross $4.83M.
- 2024-12-31: Property, Plant and Equipment, Gross $12.11M.
- 2023-12-31: Property, Plant and Equipment, Gross $11.21M.
- 2022-12-31: Property, Plant and Equipment, Gross $10.88M.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2025-12-31 | $4.83M 10-K · filed 2026-02-19 |
| 2024-12-31 | $12.11M 10-K · filed 2026-02-19 |
| 2023-12-31 | $11.21M 10-K · filed 2025-02-20 |
| 2022-12-31 | $10.88M 10-K · filed 2024-02-22 |
| 2021-12-31 | $18.25M 10-K · filed 2023-03-02 |
| 2020-12-31 | $16.39M 10-K · filed 2022-02-28 |
| 2019-12-31 | $16.06M 10-K · filed 2021-03-08 |
| 2018-12-31 | $15.80M 10-K · filed 2020-03-06 |
| 2017-12-31 | $15.62M 10-K · filed 2019-03-06 |
| 2016-12-31 | $14.09M 10-K · filed 2018-03-14 |
| 2015-12-31 | $8.52M 10-K · filed 2017-02-17 |
| 2014-12-31 | $5.76M 10-K · filed 2016-03-04 |
| 2013-12-31 | $3.86M 10-K · filed 2015-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |